Jenscare Scientific Co (HKSE:09877) Net Cash per Share : HK$2.62 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Jenscare Scientific Co's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$2.62.

The historical rank and industry rank for Jenscare Scientific Co's Net Cash per Share or its related term are showing as below:

HKSE:09877' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.48 Med: 20.36 Max: 32.24
Current: 1.49

During the past 4 years, the highest Price-to-Net-Cash Ratio of Jenscare Scientific Co was 32.24. The lowest was 1.48. And the median was 20.36.

HKSE:09877's Price-to-Net-Cash is ranked better than
91.41% of 326 companies
in the Medical Devices & Instruments industry
Industry Median: 7.21 vs HKSE:09877: 1.49

Jenscare Scientific Co Net Cash per Share Historical Data

The historical data trend for Jenscare Scientific Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co Net Cash per Share Chart

Jenscare Scientific Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

0.93

2.20

2.05

2.62

Jenscare Scientific Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Cash per Share	Get a 7-Day Free Trial			2.20	1.93	2.05	1.79	2.62

Competitive Comparison of Jenscare Scientific Co's Net Cash per Share

For the Medical Devices subindustry, Jenscare Scientific Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jenscare Scientific Co's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Jenscare Scientific Co's Price-to-Net-Cash falls into.

Jenscare Scientific Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Jenscare Scientific Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1196.883	-	110.294	-	-7.24)	/	417.167
=	2.62

Jenscare Scientific Co's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

	Net Cash per Share (Q: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1196.883	-	110.294	-	-7.24)	/	417.167
=	2.62

Jenscare Scientific Co (HKSE:09877) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Jenscare Scientific Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Jenscare Scientific Co (HKSE:09877) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN

Website

https://www.jenscare.com

Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.

Executives

Shanghai Jiachen Investment Co.,ltd	2201 Interest of corporation controlled by you
Li Hui	2501 Other
Lv Shiwen	2501 Other
Ningbo Dixiang Venture Capital Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Shidi Industrial Development Co., Ltd.	2501 Other
Ningbo Sangdi Investment Management L.p. (limited Partnership)	2101 Beneficial owner
Ningbo Linfeng Biotechnology Co., Ltd.	2101 Beneficial owner
Pan Fei	2201 Interest of corporation controlled by you
Hainan Yize Medical Technology Co., Limited	2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership)	2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership)	2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership)	2101 Beneficial owner
Ningbo Mukang Venture Capital Partnership (limited Partnership)
Li Hui

Jenscare Scientific Co (HKSE:09877) Headlines

No Headlines